{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:03:27Z","timestamp":1768741407072,"version":"3.49.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/pas.0b013e3181be5d72","type":"journal-article","created":{"date-parts":[[2009,12,21]],"date-time":"2009-12-21T15:46:44Z","timestamp":1261410404000},"page":"18-26","source":"Crossref","is-referenced-by-count":47,"title":["HMGA2: A Potential Biomarker Complement to P53 for Detection of Early-stage High-grade Papillary Serous Carcinoma in Fallopian Tubes"],"prefix":"10.1097","volume":"34","author":[{"given":"Jian-Jun","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana","family":"Yeldandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pacita","family":"Keh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"2","key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/modpathol.3800306","article-title":"Origins and molecular pathology of ovarian cancer","volume":"18","author":"Bell","year":"2005","journal-title":"Mod Pathol"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"key":"R3-3-20210131","first-page":"289","article-title":"The HMGA proteins: a myriad of functions (Review)","volume":"32","author":"Cleynen","year":"2008","journal-title":"Int J Oncol"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc2271","article-title":"Roles of HMGA proteins in cancer","volume":"7","author":"Fusco","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<316::AID-GCC2>3.0.CO;2-0","article-title":"HMGIC expression in human adult and fetal tissues and in uterine leiomyomata","volume":"25","author":"Gattas","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-6-5","article-title":"High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma","volume":"6","author":"Hebert","year":"2007","journal-title":"Mol Cancer"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/modpathol.2008.140","article-title":"HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma","volume":"22","author":"Hristov","year":"2009","journal-title":"Mod Pathol"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med"},{"key":"R12-3-20210131","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.23491","article-title":"HMGA2 gene is a promising target for ovarian cancer silencing therapy","volume":"123","author":"Malek","year":"2008","journal-title":"Int J Cancer"},{"key":"R17-3-20210131","first-page":"182","article-title":"Role of genome research in the diagnosis and therapy of ovarian cancer","volume":"51","author":"Malek","year":"2005","journal-title":"Vopr Onkol"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cell.2006.05.052","article-title":"A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation","volume":"126","author":"Narita","year":"2006","journal-title":"Cell"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","article-title":"Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2","volume":"6","author":"Park","year":"2007","journal-title":"Cell Cycle"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/1541-7786.MCR-07-0370","article-title":"Antiproliferative effects by let-7 repression of high-mobility group A2 in uterine leiomyoma","volume":"6","author":"Peng","year":"2008","journal-title":"Mol Cancer Res"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1289\/ehp.00108s5803","article-title":"Structure and function of the HMGI(Y) family of architectural transcription factors","volume":"108","author":"Reeves","year":"2000","journal-title":"Environ Health Perspect"},{"key":"R24-3-20210131","first-page":"775","article-title":"HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors","volume":"149","author":"Rogalla","year":"1996","journal-title":"Am J Pathol"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2008.07.018","article-title":"Risk factors for a serous cancer precursor (\u201cp53 signature\u201d) in women with inherited BRCA mutations","volume":"111","author":"Saleemuddin","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0039-6109(16)41439-8","article-title":"Carcinoma of the fallopian tube","volume":"58","author":"Sedlis","year":"1978","journal-title":"Surg Clin North Am"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1073\/pnas.0704372104","article-title":"Let-7 expression defines two differentiation stages of cancer","volume":"104","author":"Shell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih Ie","year":"2004","journal-title":"Am J Pathol"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"33437","DOI":"10.1074\/jbc.M802016200","article-title":"HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition","volume":"283","author":"Thuault","year":"2008","journal-title":"J Biol Chem"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/1535-7163.MCT-05-0048","article-title":"Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody","volume":"4","author":"Wang","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2353\/ajpath.2009.080523","article-title":"HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells","volume":"174","author":"Watanabe","year":"2009","journal-title":"Am J Pathol"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","article-title":"Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer","volume":"98","author":"Welsh","year":"2001","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-201001000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:05:42Z","timestamp":1618038342000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201001000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e3181be5d72","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}